News
Latest News
- 29 Mar 2021 – Destiny Pharma to Join Equity Development Webinar
- 29 Mar 2021 – Destiny Pharma Phase 2b results – Analyst and Investor webcast and conference call details – Monday 29th March at 1100 BST
- 29 Mar 2021 – Destiny Pharma Reports Positive Phase 2b Results for XF-73 Nasal Gel
- 16 Mar 2021 – Notice of Full Year Results and Clinical Trial Update
- 15 Mar 2021 – Destiny Pharma Announces Agreement with NIAID
- 10 Mar 2021 – Destiny Pharma CSO Joins UKRI COVID-19 Taskforce
- 03 Feb 2021 – Destiny Pharma announces Brazilian Patent granted for XF-73 nasal gel
- 02 Feb 2021 – Destiny Pharma to join panel discussion at the 7th Annual LSX World Congress 2021
- 02 Feb 2021 – Destiny Pharma appoints Professor Mark Wilcox to Scientific Advisory Board
- 27 Jan 2021 – Destiny Pharma welcomes Matt Hancock’s statement saying G7 will focus on AMR